Cargando…

CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity

BACKGROUND: Purkinje cytoplasmic autoantibody type 1 (PCA-1)/anti-Yo autoimmunity is a common high-risk paraneoplastic neurological disorder, traditionally attributed antigenically to cerebellar degeneration–related protein 2 (CDR2), predominantly affecting women with gynecologic or breast adenocarc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vorasoot, Nisa, Scharf, Madeleine, Miske, Ramona, Thakolwiboon, Smathorn, Dubey, Divyanshu, Mills, John R., Pittock, Sean J., Zekeridou, Anastasia, Ott, Anthonina, McKeon, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570841/ https://www.ncbi.nlm.nih.gov/pubmed/37841252 http://dx.doi.org/10.3389/fimmu.2023.1265797

Ejemplares similares

CDR2 antigen and Yo antibodies
por: Totland, Cecilie, et al.
Publicado: (2010)

Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration
por: Herdlevær, Ida, et al.
Publicado: (2020)

Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease
por: McKeon, Andrew, et al.
Publicado: (2023)

Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis
por: Schubert, Manja, et al.
Publicado: (2014)

A comparison of tissue-based and recombinant protein–based assays for detecting PCA-Tr/DNER-IgG
por: Alfugham, Nora, et al.
Publicado: (2016)

Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments
por: Shah, Shailee, et al.
Publicado: (2021)

Phenotypic presentations of paraneoplastic neuropathies associated with MAP1B-IgG
por: Jitprapaikulsan, Jiraporn, et al.
Publicado: (2020)

CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration
por: Eichler, Tilo W., et al.
Publicado: (2013)

The CLIC ILD CDR Geometry for the CDR Monte Carlo Mass Production
por: Muennich, A, et al.
Publicado: (2012)

Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome
por: Rezk, Mohamed, et al.
Publicado: (2023)

CDR update report
por: Yin, Ting
Publicado: (2019)

Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic Marker
por: Herdlevær, Ida, et al.
Publicado: (2021)

Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity
por: Zekeridou, Anastasia, et al.
Publicado: (2019)

Paraneoplastic neuronal intermediate filament autoimmunity
por: Basal, Eati, et al.
Publicado: (2018)

CDR Update for NA62
por: Yin, Ting
Publicado: (2019)

The CDR subsystem of the COMPASS experiment
por: Král, A, et al.
Publicado: (2005)

Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes
por: Shah, Shailee, et al.
Publicado: (2021)

The CLIC SiD CDR Detector Model for the CLIC CDR Monte Carlo Mass Production
por: Grefe, C, et al.
Publicado: (2011)

Autoantibodies Against the Purkinje Cell Protein RGS8 in Paraneoplastic Cerebellar Syndrome
por: Miske, Ramona, et al.
Publicado: (2021)

Multi Step Selection in Ig H Chains is Initially Focused on CDR3 and Then on Other CDR Regions
por: Liberman, Gilad, et al.
Publicado: (2013)

Referee Reports on the CDR of the LHeC
por: Huebner, K, et al.
Publicado: (2012)

Light Higgs Studies for the CLIC CDR
por: Grefe, Christian, et al.
Publicado: (2012)

CLICdet: The post-CDR CLIC detector model
por: Alipour Tehrani, Niloufar, et al.
Publicado: (2017)

Automatic CDR Estimation for Early Glaucoma Diagnosis
por: Fernandez-Granero, M. A., et al.
Publicado: (2017)

Comparative Analysis of the CDR Loops of Antigen Receptors
por: Wong, Wing Ki, et al.
Publicado: (2019)

Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme
por: Barbagallo, Davide, et al.
Publicado: (2015)

Subcortical Vascular Cognitive Impairment staged through cdr's functional subsum (cdr-func): Preliminary results from an outpatient sample()()
por: Sudo, Felipe Kenji, et al.
Publicado: (2016)

Evolution of immunogenetic components encoding ultralong CDR H3
por: Ott, Jeannine A., et al.
Publicado: (2023)

Effect of Allium cepa loaded polyacrylonitrile and polyvinyl pyrrolidone nanofibers on Candida albicans growth and the expression of CDR1 and CDR2 genes
por: Nademi, Azam, et al.
Publicado: (2021)

Effect of new methionine-based ionic liquid on the CDR1 and CDR2 gene expression on sensitive and resistant strains of Candida albicans
por: Eslami, Mona, et al.
Publicado: (2023)

Intensive Combination Immunotherapy and Neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies
por: Philipps, Guillermo, et al.
Publicado: (2018)

CDR3 length in antigen-specific immune receptors
Publicado: (1994)

Software and Parameters for Detailed TPC Studies in the CLIC CDR
por: Killenberg, M.
Publicado: (2011)

Immunoglobulin Structure Exhibits Control over CDR Motion
por: Zimmermann, Michael T., et al.
Publicado: (2011)

Canonical structures of short CDR-L3 in antibodies
por: Teplyakov, Alexey, et al.
Publicado: (2014)

The composition and variation of the BCR CDR3s in gastric cancer
por: Liu, Song, et al.
Publicado: (2018)

Burden sharing for CDR: balancing fair liability with feasibility
por: Jones, Chris D
Publicado: (2023)

Clinical spectrum of high-titre GAD65 antibodies
por: Budhram, Adrian, et al.
Publicado: (2021)

Autoimmune Encephalitis Criteria in Clinical Practice
por: Orozco, Emma, et al.
Publicado: (2023)

Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_b15s5pukss6lng1md6153h2phi